Acetylcholine, Another Factor in Breast Cancer

Acetylcholine, Another Factor in Breast Cancer

Acetylcholine (ACh) is a neurotransmitter that regulates multiple functions in the nervous system, and emerging evidence indicates that it could play a role in cancer progression. However, this function is controversial. Previously, we showed that organophosphorus pesticides decreased the levels of...

Full description

Bibliographic Details
Main Authors:	Juan P. Muñoz, Gloria M. Calaf
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Biology
Subjects:	acetylcholine estrogens estrogen receptor alpha muscarinic receptor breast cancer
Online Access:	https://www.mdpi.com/2079-7737/12/11/1418

Similar Items

Effects of Curcumin and Estrogen Receptor Alpha in Luminal Breast Cancer Cells
by: Lorena Palacios-Navarro, et al.
Published: (2024-08-01)

Understanding the Role of Estrogen Receptor Status in PRODH/POX-Dependent Apoptosis/Survival in Breast Cancer Cells
by: Sylwia Lewoniewska, et al.
Published: (2021-12-01)

Impact of the type of breast cancer on the biodiversity of the vaginal Candida represented by estrogen receptor and its levels
by: Ali Abdul Hussein S. AL-Janabi, et al.
Published: (2023-12-01)

Anticancer activity of Hedyotis corymbosa nanoliposomes targeting estrogen receptor-alpha in breast cancer cells: In silico and in vitro studies
by: Sofy Permana, et al.
Published: (2024-03-01)

Obesity and breast cancer
by: A. I. Berishvili, et al.
Published: (2022-12-01)

Contrary effects of the gut metabolites deoxycholate and butyrate on the acetylcholine-evoked calcium response in an enteroendocrine cell model
by: Beatrix Pfanzagl, et al.
Published: (2024-06-01)

The relationship between bipolar disorder and breast cancer: a two-sample Mendelian randomization study
by: MA Tingting, et al.
Published: (2025-02-01)

Receptor Status Differences in Prognosis for Breast Cancer
by: Yelda Deligöz Bildacı, et al.
Published: (2024-07-01)

Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives
by: Christina Panagiotis Malainou, et al.
Published: (2023-11-01)

Androgen receptor expression and clinical characteristics in breast cancer
by: Dan-dan Wang, et al.
Published: (2024-09-01)

Effects of Different Photoperiods on Growth Performance, Glucose Metabolism, Acetylcholine, and Its Relative Acetylcholine Receptor Modulation in Broiler Chickens
by: Miao Yu, et al.
Published: (2024-10-01)

Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma
by: Daniela Nahmias Blank, et al.
Published: (2022-09-01)

Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer
by: Jin J, et al.
Published: (2024-01-01)

A review of endocrine therapy for hormone-dependent breast cancer
by: A. N. Useinova, et al.
Published: (2024-07-01)

Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status
by: Julian C. McClellan, et al.
Published: (2024-03-01)

Studi In Silico Aktivitas Senyawa Steroid Terhadap Antikanker Payudara Menggunakan Estrogen Alfa (ER-α)
by: Nurlelasari Nurlelasari, et al.
Published: (2023-03-01)

Investigation of a Radio-Iodinated Alpha-Mangostin for Targeting Estrogen Receptor Alpha (ERα) in Breast Cancer: In Silico Design, Synthesis, and Biological Evaluation
by: Muchtaridi M, et al.
Published: (2024-10-01)

Genetic and clinical landscape of ER + /PR- breast cancer in China
by: Danian Dai, et al.
Published: (2023-12-01)

Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal <i>BRCA1</i>-associated breast cancer to triple negative subtype in lung metastasis and PARP inhibition strategy in early-line therapy
by: A. I. Stukan, et al.
Published: (2022-12-01)

Correlation of interleukin 6 (IL-6) with estrogen and progesterone receptor expression in breast cancer patients
by: Amal K. Chaloob
Published: (2011-01-01)

Correlation of quantitative measures of estrogen receptor α and β expression in non-small cell lung cancer tissue with clinical characteristics of the disease
by: T. A. Bogush, et al.
Published: (2021-08-01)

Thiourea Derivatives as Estrogen Receptor Alpha Inhibitors for Breast Cancer Therapy: An In Silico Evaluation with ADMET Prediction and Molecular Docking
by: Hestining Puspaweni, et al.
Published: (2024-08-01)

Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up
by: Helena Fohlin, et al.
Published: (2024-07-01)

Advances in the study of the role of estrogen and its receptor combined with HPV in cervical cancer microenvironment
by: LI He-tong, REN Jing-jing, WANG Wen-hao, HAO Min
Published: (2022-09-01)

Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies
by: Cristina Ferreira Almeida, et al.
Published: (2024-09-01)

Genistein: A Potent Anti-Breast Cancer Agent
by: Smitha S. Bhat, et al.
Published: (2021-10-01)

Immunohistochemical tests for diagnostics of infiltrative forms of breast cancer and identification of molecular subtype in women of different ages in Dnipro city
by: T. M. Shevchenko, et al.
Published: (2017-04-01)

The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer
by: Marianna Talia, et al.
Published: (2024-06-01)

A PROSPECTIVESTUDY OF ESTROGEN, PROGESTRONE AND HER2NEU RECEPTOR IN CASES OF BREAST CANCER IN A TERTIARY CARE HOSPITAL OF BHAVNAGAR, GUJARAT, WESTERN INDIA
by: Hathila Tejas N, et al.
Published: (2015-09-01)

<i>Synaptotagmin 13</i> Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer
by: Takahiro Ichikawa, et al.
Published: (2021-10-01)

CLINICAL CHARACTERISTICS OF BREAST CANCER WITH STEROID RECEPTORS EXPRESSION AND HER2 AMPLIFICATION
by: F. V. Moiseenko, et al.
Published: (2017-02-01)

Molecular characterization of breast cancer cell pools with normal or reduced ability to respond to progesterone: a study based on RNA-seq
by: Mariana Bustamante Eduardo, et al.
Published: (2023-08-01)

The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens
by: Marília I. Figueira, et al.
Published: (2024-07-01)

Editorial: Underlying molecular interconnections of the estrogen receptor alpha and associated factors involved in breast cancer development: the way to new therapeutic approaches, volume II
by: Philipp Y. Maximov, et al.
Published: (2024-06-01)

Risk factors for late recurrence and postrelapse survival in estrogen receptor (ER)-positive, human epidermal growth factor receptor (HER) 2-negative breast cancer after 5 years of endocrine therapy
by: Masahiro Ito, et al.
Published: (2024-02-01)

The Relationship between Time, Race, and Estrogen Receptor Alpha in Estradiol-Induced Dermal Fibrosis
by: DeAnna Baker Frost, et al.
Published: (2024-01-01)

New generation estrogen receptor-targeted agents in breast cancer: present situation and future prospectives
by: Jian Min, et al.
Published: (2024-03-01)

Androgen receptor expression and clinical significance in breast cancer
by: Ningning Yao, et al.
Published: (2025-02-01)

An observational study of association of clinicopathological stage and Ki-67, P53, human epidermal growth factor receptor 2/neu, estrogen receptor, and progesterone receptor status in breast cancer
by: Rachin Sharma, et al.
Published: (2024-01-01)

Multiregional Radiomic Signatures Based on Functional Parametric Maps from DCE-MRI for Preoperative Identification of Estrogen Receptor and Progesterone Receptor Status in Breast Cancer
by: Shiling Zhong, et al.
Published: (2022-10-01)